Eleventx
ScionxBio is seeking a Synthetic Chemist in Cambridge, UK, to design and synthesise chemically modified nucleosides and nucleotides for next-generation RNA therapeutics. The role involves developing robust phosphorylation routes, purifying polar nucleotide species, and characterising products to support RNA stability and delivery improvements. This position offers the opportunity to work in a collaborative, interdisciplinary environment alongside chemists, molecular biologists, and AI specialists.
Headquarters
Cambridge, England, United Kingdom
Company Size
11-50 employees
Founded
2020
Eleven Therapeutics (ElevenTx) is a biotechnology company that combines combinatorial chemistry and machine learning to transform RNA interference (RNAi) drug discovery into a programmable, scalable process. Using a proprietary chemistry-and-AI platform, the company designs and optimizes RNAi molecules and associated chemistries to accelerate discovery and preclinical development. Its goal is to enable more rapid, predictable development of RNAi therapeutics across a range of genetic and acquired diseases.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Eleventx.
Eleventx didn’t post a salary, so this is our estimate from similar listings.
9% above the average for this role
Chemistry R&D Senior Research Associate
Sarmal
Synthesis Scientist
Eli Lilly and Company
Senior Scientist (Organic Chemist-Oligonucleotide Delivery)
Amgen
Senior Scientist - Synthetic Chemist in Oligonucleotide Therapeutics
AstraZeneca
Synthetic DNA Process Development Scientist
Eurofins
Scientist I
Prime Medicine